Pemetrexed Disodium With or Without Erlotinib Hydrochloride in Treating Patients With Stage IIIB-IV or Recurrent Non-Small Cell Lung Cancer

Clinical trial NCT00950365 · COMPLETED

Trial details

NCT number: NCT00950365
Sponsor: Albert Einstein College of Medicine
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Bronchioloalveolar Carcinoma Large Cell Lung Carcinoma Lung Adenocarcinoma Recurrent Non-Small Cell Lung Carcinoma Stage IIIB Non-Small Cell Lung Cancer Stage IV Non-Small Cell Lung Cancer

Start date: 2006-04-01
Primary completion: 2017-11-17
Enrollment: 79

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.